CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Synergy Chc Corp.  (SNYR)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Equipment & Supplies
 
 

SNYR's Revenue Year on Year Growth by Quarter and Year

Synergy Chc.'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
SNYR Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 6.73 6.22 0.01
III Quarter September - 11.57 3.18 -
II Quarter June - 8.27 2.46 -
I Quarter March 10.79 8.27 1.60 -
FY   10.79 34.84 13.46 0.01

Financial Statements
Synergy Chc.'s first quarter 2017 Revenue $ 10.79 millions SNYR's Income Statement
Synergy Chc.'s first quarter 2016 Revenue $ 8.27 millions Quarterly SNYR's Income Statement
SNYR's Growth by Division See SNYR's Growth by Segment

SNYR Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 8.2 % 62100 % -
III Quarter September - 263.84 % - -
II Quarter June - 236.18 % - -
I Quarter March 30.45 % 416.88 % - -
FY   - 158.84 % 134500 % -



SNYR Revenue Growth Comment
Synergy Chc Corp. reported Revenue improvement of 30.45% year on year in the first quarter, to $ 10.79 millions, this is lower than Synergy Chc Corp.'s recent average Revenue surge of 26733.9%.

Looking into first quarter results within Medical Equipment & Supplies industry 20 other companies have achieved higher Revenue growth. While Synergy Chc Corp.' s Revenue rise of 30.45% ranks overall at the positon no. 638 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #21
Healthcare Sector #109
S&P 500 #638
Revenue Y/Y Growth Statistics
High Average Low
96916.51 % 26733.9 % 8.2 %
(Dec 31 2015)   (Dec 31 2016)

You need to upgrade your Flash Player

Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SNYR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for SNYR's Competitors
Revenue Growth for Synergy Chc.'s Suppliers
Revenue Growth for SNYR's Customers

You may also want to know
SNYR's Annual Growth Rates SNYR's Profitability Ratios SNYR's Asset Turnover Ratio SNYR's Dividend Growth
SNYR's Roe SNYR's Valuation Ratios SNYR's Financial Strength Ratios SNYR's Dividend Payout Ratio
SNYR's Roa SNYR's Inventory Turnover Ratio SNYR's Growth Rates SNYR's Dividend Comparisons



Companies with similar Revenue rise for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Psychemedics Corp  53.13 %$ 53.126 millions
Axogen, Inc.  50.91 %$ 50.905 millions
Wound Management Technologies, Inc.  46.57 %$ 46.568 millions
Lexicon Pharmaceuticals, Inc.  46.41 %$ 46.414 millions
Incyte Corp  45.78 %$ 45.782 millions
Stemline Therapeutics Inc  45.59 %$ 45.587 millions
Immunogen Inc  44.56 %$ 44.562 millions
Diversicare Healthcare Services, Inc.  44.47 %$ 44.469 millions
Natus Medical Inc  42.75 %$ 42.748 millions
Invuity, Inc.  40.90 %$ 40.896 millions
Ptc Therapeutics, Inc.  40.50 %$ 40.497 millions
Select Medical Holdings Corp  39.73 %$ 39.734 millions
Imprimis Pharmaceuticals, Inc.  39.17 %$ 39.169 millions
Bellicum Pharmaceuticals, Inc.  39.13 %$ 39.130 millions
Semler Scientific, Inc.  36.91 %$ 36.909 millions
Mimedx Group, Inc.  36.05 %$ 36.052 millions
Amarin Corp Plcuk  35.60 %$ 35.603 millions
Novavax Inc  34.66 %$ 34.661 millions
Momenta Pharmaceuticals Inc  34.08 %$ 34.076 millions
Aytu Bioscience, Inc  33.66 %$ 33.656 millions
Nobilis Health Corp.  33.21 %$ 33.212 millions
Misonix Inc  32.28 %$ 32.281 millions
Cutera Inc  30.66 %$ 30.665 millions
Synergy Chc Corp.  30.49 %$ 30.487 millions
Supernus Pharmaceuticals Inc  30.28 %$ 30.280 millions
Pacific Biosciences Of California, Inc.  30.26 %$ 30.261 millions
Align Technology Inc  30.00 %$ 30.002 millions
Abbott Laboratories  29.68 %$ 29.683 millions
Idera Pharmaceuticals, Inc.  28.57 %$ 28.571 millions
Biomarin Pharmaceutical Inc  28.31 %$ 28.305 millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
SPLS's Profile
Stock Price
SPLS's Financials
SPLS's Expectations
Business Description
Fundamentals
Charts & Quotes
SPLS's News
Suppliers
SPLS's Competitors
Customers & Markets
Economic Indicators
SPLS's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com